Lars Fruergaard Jorgensen’s departure comes a week after ... says she cried for three days after reading Cassie’s lawsuit California union leader David Huerta is released from custody on ...

Lars Fruergaard Jorgensen's departure comes a week after the company downgraded ... HUSKY C has both the lowest income and asset eligibility limits of any of the state's Medicaid program, the lawsuit ...

ANALYSIS· May 16, 2025 Novo Nordisk should look to the US for its next CEO, analysts say As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look ...

ANALYSIS· May 16, 2025 Novo Nordisk should look to the US for its next CEO, analysts say As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look ...

LEXINGTON, Ky. — Two former Kentucky swim team members have sued the school, former coach Lars Jorgensen and athletic director Mitch Barnhart, alleging sexual assaults including rape by the former ...

Lars Fruergaard Jorgensen's departure comes a week after the company downgraded its sales and profits forecast, and follows a more than 50% decline in the company's shares since mid-2024.

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Novo Nordisk A/S is replacing Chief Executive Officer Lars Fruergaard Jorgensen as the drugmaker wrestles with increased competition for its Wegovy obesity shots that transformed the weight-loss ...

COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly ...

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down as competition in the weight-loss drug space pressured the company's stock. "Considering the recent market challenges, the share price ...

Lars Fruergaard Jorgensen’s departure comes a week after the company downgraded its sales and profits forecast and follows a more than 50% decline in the company’s shares since mid-2024.